Effect of a novel leukotoriene synthesis inhibitor, BAY x1005, on the antigen- and LPS-induced airway hyperresponsiveness in guinea pigs |
| |
Authors: | Hiroichi Nagai Hiroshi Takeda Takashi Uno Hiroyuki Tanaka Akihiko Matsuo |
| |
Institution: | Department of Pharmacology, Gifu Pharmaceutical University 5-6-1 Mitahorahigashi, Gifu 502, Japan |
| |
Abstract: | Due to the inhibition of 5-lipoxygenase-activating protein (FLAP), BAY x1005 is a new selective inhibitor of leukotriene synthesis. The effects of BAY x1005 on the antigen- and bacterial lipopolysaccharide (LPS)-induced airway hyperresponsiveness in guinea pigs were investigated. Six times provocation of aeroantigen caused biphasic increases in airway resistance which peaked at 1 hr (immediate phase reaction) and 4 hrs (late phase reaction). It also caused airway hyperreactivity to acetylcholine. BAY x1005 at doses of 10mg/kg and 30mg/kg significantly inhibited antigen-induced increase in respiratory resistance (Rrs) at 1 and 4 hrs after the last antigen challenge. Simultaneously, BAY x1005 inhibited the antigen-induced airway hyperresponsiveness at doses of 10 and 30mglkg and airway eosinophilia (bronchoalveolar lavage study) at a dose of 30 mg/kg. In addition, BAY x1005 at a dose of 30mg/kg inhibited bacterial LPS-induced airway hyperreactivity to acetylcholine. In this model, BAY x1005 did not affect the increase of the number of leukocytes in bronchoalveolar lavage fluid.These results suggest that BAY x1005 is a potent anti-asthmatic agent with an inhibitory action to airway hyperreactivity. |
| |
Keywords: | BAY x1005 leukotriene synthesis inhibitor anti-asthmatic action airway hyperreactivity |
本文献已被 ScienceDirect 等数据库收录! |